Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
What Could Push Kbr Kbr Stock Higher Price At 37.02 Down 1.28 20260410 What Is The Price Target For Perion Network Peri Stock Price At 9.87 Up 0.51 20260402 Should I Buy Expensify Exfy Stock Now Exfy Q4 2025 Earnings Expensify Inc. Misses Eps Estimates No Revenue Disclosed 20260413 1 Is Functional Brands Meha Stock Declining Price At 0.17 Up 0.60 20260413 Daily Market Overview Three Major Us Indices Close Higher Nasdaq Leads With 0.37 Pct Gain 20260406 1 DAWN Day One Biopharmaceuticals Inc reports wider than expected Q4 2025 loss shares tick marginally higher in todays trading What First FXNC segment performance reveals Q1 2026 Earnings Fall Short Aeva AEVA Stock Market Sentiment Surges Ahead 20260418 Is Cullinan CGEM stock showing weakness 217 20260418 Why Pimco PCN looks attractive at current levels Steady 20260511 GYRO Gyrodyne LLC leadership outlines new cost optimization plans in its latest quarterly earnings update International IGIC Stock Good Opportunity Overhead Buying 20260420 Exicure XCUR Stock Next Week Touches Low 20260420 Teledyne TDY Stock Growth Outlook CLRO ClearOne beats Q2 earnings estimates despite continued losses yet shares slide 54 on outlook concerns The MA impact hidden in Vornado VNOO earnings What the smart money sees in Beta Tech BETA that retail does not Technical Weakness 20260508 EEFT Euronet Worldwide reports 67 percent Q1 2026 EPS beat but shares drop 392 percent in todays session Biogen Inc BIIB Q1 2026 Earnings Beat Drives 6 SingleDay Gain Despite FullYear Guidance Cut Bond Market Pressures Mount as Kevin Warsh Prepares to Shrink Fed Balance Sheet Cencora COR Emerges as a Healthcare Leader with Robust Fundamentals and Strategic ReRating BEN Warrant BNAIW Falls 1274 Watching 013 Support 20260515 NACHO Trade Takes Center Stage But Memory Chipmaker Rally May Still Have Room to Run The Brand TBHC Steady at 094 Awaiting Next Catalyst 20260518 Dave Inc DAVE Slides 147 as Selling Pressure Mounts 20260514 First FCNCA Q1 2026 Beat Revenue NA EPS Exceeds by Significant UK Economy Defies Analysts with 03 Growth in March Amid Iran Conflict Retail Hiring Surges by 22000 Jobs in April Yet Consumer Sentiment Flashes Caution ATT CEO Highlights BlueCollar Worker Shortage in AIDriven Economy Indian Markets Edge Higher on Easing Geopolitical Tensions Analyst Highlights Five Stocks for May 21 AllegroMicro ALGM Posts Record Q1 2026 EPS 017 Blows Past Estimates Josh Harts Resurgence Fuels New York Knicks Postseason Momentum Andhra Pradesh Leads in Petrol Prices Gujarat Offers Lowest Rates Across Indian States Personal Debt Alert Mans 169000 Spiral Blamed on ExWifes Cheating Nvidia Stock Declines PostEarnings Why Some Market Participants May Be Overlooking LongTerm Potential JRs Inflatable Cave on Paris Bridge Could Spark Cultural Tourism Interest FUL Q1 2026 Earnings EPS Slightly Beats Estimates as Stock Rises 25 GLMD Q4 2025 Earnings WiderThanExpected Loss as Galmed Continues Clinical Development Navios Maritime Partners NMM Q1 2026 Earnings EPS Beats Estimates by 171 Despite Slight Stock Pullback Sunshine Biopharma Inc SBFM Q1 2026 Earnings Reported Loss Per Share of 025 Stock Declines 68 ELTX Q1 2026 Earnings EPS Miss as ClinicalStage Biotech Advances Pipeline Without Revenue Aclaris Therapeutics ACRS Holds Near Support as Volume Suggests Cautious Sentiment HNI Corporation HNI Slips 055 as Trading Remains RangeBound Amid Sector Headwinds Upland Software UPLD Edges Lower Near Key Support Level Madison Square Garden Entertainment MSGE Holds Steady Amid Narrow Trading Range RFAI RF Acquisition Corp II Ordinary Shares reports Q1 2026 EPS of 024 while pursuing viable SPAC acquisition opportunities Claritev CTEV Stock Downtrend Eye on Rally 20260415 NGVT Ingevity Corporation posts Q4 2025 EPS miss but shares rise as investors look past nearterm headwinds The margin expansion playbook at BioRestor BRTX Q4 2025 Earnings Beat Estimates ATNM Actinium Pharmaceuticals Inc Delaware gains four percent after Q4 2025 results despite slight EPS miss against analyst expectations